Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional) | RFA AG 20 002

Opportunity Information: Apply for RFA AG 20 002

The National Institutes of Health (NIH) is soliciting applications for a Research and Development Center grant mechanism (P30) under the funding opportunity titled "Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)" (Funding Opportunity Number: RFA-AG-20-002; CFDA: 93.866). The purpose of this opportunity is to build or strengthen centers that concentrate on demography, economics, and health services research connected to Alzheimer's disease and Alzheimer's related dementias (AD/ADRD). In practical terms, the FOA is aimed at supporting institutional hubs that can organize data resources, shared infrastructure, and coordinated research programs to generate evidence that improves understanding of dementia at the population level, including how care is delivered, paid for, and experienced.

The scientific emphasis is squarely on population and systems questions rather than basic biology. NIH highlights a set of priority topics that are especially encouraged. These include national and international trends in cognitive aging and AD/ADRD, as well as the demography of dementia care and caregiving, which covers who provides care, how caregiving is structured, and how these patterns are changing over time. The FOA also prioritizes work on the economic burden of AD/ADRD, meaning analyses of costs to patients and families, health systems, insurers, and society, including direct medical spending and indirect costs such as lost productivity or uncompensated caregiving time.

A major portion of the encouraged scope centers on how health care and long-term services and supports shape outcomes. This includes studying how different health care systems and long-term care arrangements affect people living with dementia and their care partners, and how health care financing policies (for example, coverage rules, reimbursement design, and payment reforms) influence access, quality, utilization, and patient and caregiver outcomes. The FOA also explicitly calls for research on how regulatory and economic incentives affect access and quality across both health care and long-term care settings, recognizing that provider behavior and system performance are often driven by the incentives embedded in policy and payment structures.

Equity and effectiveness at scale are also central themes. NIH encourages research on disparities in access to and quality of dementia care, which can include differences by race, ethnicity, socioeconomic status, geography, disability status, or other factors that influence whether people receive timely diagnosis, appropriate treatment, and supportive services. Another encouraged topic is the effect of population-level health delivery and care interventions, meaning evaluations of large-scale programs or systemwide changes intended to improve outcomes for people with dementia and those who support them. Finally, the FOA highlights projections of dementia incidence, prevalence, and overall caseload in the United States and internationally, reflecting the need for forward-looking estimates that can guide planning for workforce, financing, caregiver support, and long-term care capacity.

From an eligibility standpoint, the announcement is broad and includes many types of U.S.-based organizations: state, county, and municipal governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

At the same time, there are important limits on foreign participation. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply as the applicant organization. However, foreign components are allowed under NIH policy as defined in the NIH Grants Policy Statement, which generally means a U.S. applicant may include certain foreign collaborations or activities if they are well-justified and meet NIH requirements, even though a foreign institution cannot be the primary applicant.

Administratively, this is a discretionary grant opportunity with NIH as the funding agency. The original closing date listed is 2019-06-03, and the opportunity record shows a creation date of 2018-10-30. The notice indicates that clinical trials are optional, meaning applicants can propose studies that include clinical trial elements if appropriate, but a clinical trial is not required for responsiveness. The award ceiling and expected number of awards are not specified in the provided source details, so applicants would typically need to consult the full FOA text and NIH budget guidance for any funding caps, project period expectations, and required center components.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2018-10-30.
• Applicants must submit their applications by 2019-06-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AG 20 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: